Clinical Trial Update: Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia [Phase 2, Phase 3]

View source ↗

Summary

A seamless Phase 2/3 trial evaluating the safety and immunogenicity of a chikungunya vaccine in Latin America and Asia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya

Drugs mentioned

• Chikungunya vaccine (Chikungunya vaccine)

Snippet

Sponsor: International Vaccine Institute | Conditions: Chikungunya | Phase 2, Phase 3 | Status: TERMINATED